Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

N/ACompletedNCT00484107

Wyeth is now a wholly owned subsidiary of Pfizer200 enrolled

Overview

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Postmenopause

Interventions

Conjugated Estrogen Cream (Premarin®)DRUG

Eligibility

Sex: FEMALEMin age: 40 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients in whom Premarin vaginal cream is indicated. * In the opinion of the investigator, sufficient intelligence and motivation for the patient to continue throughout the study. * Provide signed informed consent. Exclusion Criteria: * Patients not willing to give informed consent.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.